(Q33517336)

27 July 2017

1 reference

title

Functional brain imaging in the evaluation of psychiatric illness (English)

1 reference

27 July 2017

Van Heertum RL

1

1 reference

27 July 2017

O'Connell RA

series ordinal

2

1 reference

27 July 2017

publication date

1 January 1991

1 reference

Seminars in Nuclear Medicine

27 July 2017

published in

1 reference

27 July 2017

volume

21

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

24-39

1 reference

Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Bipolar affective disorders linked to DNA markers on chromosome 11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Diagnosis and prognosis in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Neuropathological Studies of Schizophrenia: A Selective Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Brain imaging: applications in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Computed tomography in schizophrenics and normal volunteers. I. Fluid volume

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Sulcal prominence in young chronic schizophrenic patients: CT scan findings associated with impairment on neuropsychological tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Cerebellar atrophy in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Biological studies in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Magnetic resonance brain images in schizophrenic and normal subjects: influence of diagnosis and education

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Quantitative neuroanatomy in schizophrenia. A controlled magnetic resonance imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Magnetic resonance imaging of the brain in schizophrenia. The pathophysiologic significance of structural abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Brain morphology in schizophrenia by magnetic resonance imaging (MRI).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Nuclear magnetic resonance brain imaging in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Neuroanatomical studies of major affective disorders. A review and suggestions for further research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Structural brain-imaging findings in affective disorders: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Computed tomography in affective disorders. Part I. Ventricular and sulcal measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Computed tomographic scans in patients with schizophrenia, schizoaffective, and bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Clinical correlates of lateral ventricular enlargement in bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Leukoencephalopathy in elderly depressed patients referred for ECT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Positron emission tomography in schizophrenic patients with and without neuroleptic medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Negative v positive schizophrenia. Definition and validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Regional Brain Function in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Imaging of neurotransmitter receptors in the living human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Positive vs. negative schizophrenia: a critical evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Positron emission tomographic study of affective disorders: problems and strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Reduction of prefrontal cortex glucose metabolism common to three types of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

External imaging of cerebral muscarinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

The brain: integrated three-dimensional display of MR and PET images.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Functional imaging of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Pathological cerebral blood flow during motor function in schizophrenic and endogenous depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Increased accumulation of N-isopropyl-(I-123) p-iodoamphetamine in the left auditory area in a schizophrenic patient with auditory hallucinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Single photon emission computed tomography (SPECT) with [123I]IMP in the differential diagnosis of psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

The potential value of serial cerebral SPECT scanning in the evaluation of psychiatric illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Dopamine D2 receptors in schizophrenia studied in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Single-photon emission computerised tomography (SPECT) in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

Cerebral perfusion inhomogeneities in schizophrenia demonstrated with single photon emission computed tomography and Tc99m-hexamethylpropyleneamineoxim

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2805%2980077-7

10.1016/S0001-2998(05)80077-7

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference